Lixte Biotechnology Holdings, Inc. (LIXT)

LIXT Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	3.41	4.2	5.35	4.82	5.07	2.6
Cash & Cash Equivalents	3.41	4.2	5.35	4.82	5.07	2.6
Cash Growth	-16.49%	-21.48%	10.98%	-4.84%	95.06%	-39.18%
Other Current Assets	0.17	0.11	0.21	0.27	0.16	0.07
Total Current Assets	3.59	4.31	5.56	5.09	5.23	2.67
Total Assets	3.59	4.31	5.56	5.09	5.23	2.67
Accounts Payable	0.25	0.16	0.23	0.23	0.19	0.14
Other Current Liabilities	0.22	0.16	0.17	0.08	0.03	0.09
Total Current Liabilities	0.46	0.31	0.4	0.3	0.22	0.24
Total Liabilities	0.46	0.31	0.4	0.3	0.22	0.24
Retained Earnings	-49.45	-48.48	-43.39	-37.08	-30.35	-27.09
Shareholders' Equity	3.13	3.99	5.17	4.79	5.01	2.43
Net Cash / Debt	3.41	4.2	5.35	4.82	5.07	2.6
Net Cash / Debt Growth	-16.49%	-21.48%	10.98%	-4.84%	95.06%	-39.18%
Net Cash Per Share	1.52	2.19	3.38	3.58	4.50	2.33
Working Capital	3.13	3.99	5.17	4.79	5.01	2.43
Book Value Per Share	1.39	2.08	3.27	3.56	4.44	2.18

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).